EBS Historical PE Ratio image   This EBS PE ratio history page last updated 11/8/2024
EBS Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2024
11/6/2024
9.201.375.481.7
Q2 2024
8/6/2024
9.86-2.32-9.28NA
Q1 2024
5/1/2024
1.930.592.360.8
Q4 2023
3/6/2024
3.26-0.77-3.08NA
Q3 2023
11/8/2023
2.21-0.87-3.48NA
Q2 2023
8/8/2023
7.20-1.06-4.24NA
Q1 2023
5/9/2023
9.70-3.17-12.68NA
Q4 2022
2/27/2023
14.00-0.31-1.24NA
Q3 2022
11/8/2022
19.73-1.27-5.08NA
Q2 2022
8/1/2022
34.23-0.86-3.44NA
Q1 2022
4/28/2022
36.610.180.7250.8
Q4 2021
2/24/2022
42.344.5018.002.4
Q3 2021
11/4/2021
52.61-0.36-1.44NA
Q2 2021
7/29/2021
65.220.331.3249.4
Q1 2021
4/29/2021
63.151.536.1210.3
Q4 2020
2/18/2021
117.063.6714.688.0
Q3 2020
11/5/2020
97.002.198.7611.1
Q2 2020
7/30/2020
97.021.987.9212.2
Q1 2020
4/30/2020
73.950.010.04>500
Q4 2019
2/20/2020
64.581.576.2810.3
Q3 2019
11/6/2019
58.401.214.8412.1
Q2 2019
8/1/2019
44.19-0.12-0.48NA
Q1 2019
5/2/2019
53.40-0.13-0.52NA
Q4 2018
2/21/2019
63.720.753.0021.2
Q3 2018
11/1/2018
63.860.552.2029.0
Q2 2018
8/2/2018
54.831.074.2812.8
Q1 2018
5/3/2018
50.53-0.03-0.12NA
Q4 2017
2/22/2018
49.390.742.9616.7
Q3 2017
11/2/2017
40.050.742.9613.5
Q2 2017
8/3/2017
35.220.110.4480.0
Q1 2017
5/4/2017
30.760.291.1626.5
Q4 2016
2/23/2017
29.780.742.9610.1
Q3 2016
11/7/2016
26.360.582.3211.4
Q2 2016
8/4/2016
30.69-0.18-0.72NA
Q1 2016
5/5/2016
37.850.160.6459.1
Q4 2015
2/25/2016
37.180.783.1211.9
Q3 2015
11/5/2015
33.780.833.3210.2
Q2 2015
8/6/2015
34.600.361.4424.0
Q1 2015
5/7/2015
30.81-0.50-2.00NA
Q4 2014
3/5/2015
29.240.753.009.7
Q3 2014
11/6/2014
22.490.672.688.4
Q2 2014
8/7/2014
22.860.130.5244.0
Q1 2014
5/8/2014
25.05-0.55-2.20NA
Q4 2013
3/6/2014
25.570.411.6415.6
Q3 2013
11/7/2013
18.430.361.4412.8
Q2 2013
8/5/2013
18.050.291.1615.6
Q1 2013
5/2/2013
15.10-0.22-0.88NA
Q4 2012
3/7/2013
15.220.451.808.5
Q3 2012
11/1/2012
13.720.180.7219.1
Q2 2012
8/2/2012
14.310.210.8417.0
Q1 2012
5/8/2012
15.18-0.19-0.76NA
EBS PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2024
11/6/2024
9.201.37-1.13NA
Q2 2024
8/6/2024
9.86-2.32-3.37NA
Q1 2024
5/1/2024
1.930.59-2.11NA
Q4 2023
3/6/2024
3.26-0.77-5.87NA
Q3 2023
11/8/2023
2.21-0.87-5.41NA
Q2 2023
8/8/2023
7.20-1.06-5.81NA
Q1 2023
5/9/2023
9.70-3.17-5.61NA
Q4 2022
2/27/2023
14.00-0.31-2.26NA
Q3 2022
11/8/2022
19.73-1.272.557.7
Q2 2022
8/1/2022
34.23-0.863.469.9
Q1 2022
4/28/2022
36.610.184.657.9
Q4 2021
2/24/2022
42.344.506.007.1
Q3 2021
11/4/2021
52.61-0.365.1710.2
Q2 2021
7/29/2021
65.220.337.728.4
Q1 2021
4/29/2021
63.151.539.376.7
Q4 2020
2/18/2021
117.063.677.8514.9
Q3 2020
11/5/2020
97.002.195.7516.9
Q2 2020
7/30/2020
97.021.984.7720.3
Q1 2020
4/30/2020
73.950.012.6727.7
Q4 2019
2/20/2020
64.581.572.5325.5
Q3 2019
11/6/2019
58.401.211.7134.2
Q2 2019
8/1/2019
44.19-0.121.0542.1
Q1 2019
5/2/2019
53.40-0.132.2423.8
Q4 2018
2/21/2019
63.720.752.3427.2
Q3 2018
11/1/2018
63.860.552.3327.4
Q2 2018
8/2/2018
54.831.072.5221.8
Q1 2018
5/3/2018
50.53-0.031.5632.4
Q4 2017
2/22/2018
49.390.741.8826.3
Q3 2017
11/2/2017
40.050.741.8821.3
Q2 2017
8/3/2017
35.220.111.7220.5
Q1 2017
5/4/2017
30.760.291.4321.5
Q4 2016
2/23/2017
29.780.741.3022.9
Q3 2016
11/7/2016
26.360.581.3419.7
Q2 2016
8/4/2016
30.69-0.181.5919.3
Q1 2016
5/5/2016
37.850.162.1317.8
Q4 2015
2/25/2016
37.180.781.4725.3
Q3 2015
11/5/2015
33.780.831.4423.5
Q2 2015
8/6/2015
34.600.361.2827.0
Q1 2015
5/7/2015
30.81-0.501.0529.3
Q4 2014
3/5/2015
29.240.751.0029.2
Q3 2014
11/6/2014
22.490.670.6634.1
Q2 2014
8/7/2014
22.860.130.3565.3
Q1 2014
5/8/2014
25.05-0.550.5149.1
Q4 2013
3/6/2014
25.570.410.8430.4
Q3 2013
11/7/2013
18.430.360.8820.9
Q2 2013
8/5/2013
18.050.290.7025.8
Q1 2013
5/2/2013
15.10-0.220.6224.4
Q4 2012
3/7/2013
15.220.450.6523.4
Q3 2012
11/1/2012
13.720.18NANA
Q2 2012
8/2/2012
14.310.21NANA
Q1 2012
5/8/2012
15.18-0.19NANA
Quotes delayed 20 minutes

Email EnvelopeFree EBS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Emergent BioSolutions (EBS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ECOR PE Ratio History
EDIT PE Ratio History
EGRX PE Ratio History
EHAB PE Ratio History
EHC PE Ratio History
EIGR PE Ratio History
EKSO PE Ratio History
ELAN PE Ratio History
ELDN PE Ratio History
ELEV PE Ratio History
How should the EBS historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Emergent BioSolutions. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this EBS Historical PE Ratio page.

What is the average historical PE for EBS based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The EBS historical PE ratio using the annualized quarterly earnings method works out to 19.6.

What is the average historical PE for EBS based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The EBS historical PE ratio using the TTM earnings method works out to 23.7.

On this page we presented the EBS Historical PE Ratio information for Emergent BioSolutions' stock. The average EBS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 19.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average EBS historical PE based on this TTM earnings result method is 23.7. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this EBS historical PE result, against the recent PE: when this page was posted on 11/7/2024, the most recent closing price for EBS had been 11.00, and the most recent quarterly earnings result, annualized, was 5.48. Meanwhile, the most recent TTM earnings summed to 2.55. From these numbers, we calculate the recent EBS PE on 11/7/2024 based on annualized quarterly EPS was 2.0. Based on EBS's history, that recent PE is low relative to the historical average, with the recent PE 89.8% lower than the historical average PE across our data set for Emergent BioSolutions. Looking at the recent EBS PE on 11/7/2024 based on TTM EPS, we calculate the ratio at 4.3. Based on EBS's history, that recent PE is low relative to the historical average, with the recent PE 81.9% lower than the average PE across our Emergent BioSolutions data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on EBS or any other given stock, valuation analysis for EBS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Emergent BioSolutions PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for EBS. Thanks for visiting, and the next time you need to research EBS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: CAF Historical Stock Prices, Funds Holding HYLG, Top Ten Hedge Funds Holding QABA.

 

EBS Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.